Search

Your search keyword '"Eileen Brown"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Eileen Brown" Remove constraint Author: "Eileen Brown"
67 results on '"Eileen Brown"'

Search Results

Catalog

Books, media, physical & digital resources

4. Shift

5. Shift : A New Mindset for Sustainable Execution

6. Digital Marketer

7. Relationship Between Peak Troponin Values and Long‐Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes

8. Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI

9. Thought-provoking articles

10. Outcomes for Latin American Versus White Patients Suffering From Acute Mania in a Randomized, Double-Blind Trial Comparing Olanzapine and Haloperidol

11. Making some sense of war

12. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data

13. Safety of Subchronic Treatment with Fluoxetine for Major Depressive Disorder in Children and Adolescents

14. Changes in Energy After Switching From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine

15. An excitement subscale of the Positive and Negative Syndrome Scale

17. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment

18. Reply: Not All NSTEMIs Are Created Equal

19. Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel

20. Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

21. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

22. Premenstrual Daily Fluoxetine for Premenstrual Dysphoric Disorder

23. Switching Patients From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine in the Maintenance of Response for Depression

24. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial

25. Election publication praised

26. Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

27. ASSOCIATION BETWEEN VERY LOW LEVELS OF BASELINE HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND INCREASED LONG-TERM MORTALITY IN MEDICALLY MANAGED ACUTE CORONARY SYNDROME PATIENTS

28. Reply

29. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy

30. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

32. Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy

34. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression

35. Time Course of Postischemic Intracellular Alkalosis Reflects the Duration of Ischemia

36. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study

37. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial

38. Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study

39. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

40. Budget fails aged-care workers and older people

41. Making an informed voting choice

42. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials

43. Clinical relevance of depressive symptom improvement in bipolar I depressed patients

44. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania

45. The world of nursing education funding

46. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder

48. Acute dysphoric mania: treatment response to olanzapine versus placebo

49. Avoiding back injuries and managing back pain

50. Regulating health professionals